Recent News

• 11.14.2025 - Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results
• 08.13.2025 - Mersana Q2 2025 Conference Call
• 08.13.2025 - Mersana Q2 2025 Conference Call
• 08.13.2025 - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results

Recent Filings

• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - 8-K Current report
• 11.14.2025 - SC TO-C Written communication relating to an issuer or third party
• 11.14.2025 - EX-99.1 EX-99.1
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SC14D9C Written communication relating to third party tender offer
• 11.13.2025 - SC TO-C Written communication relating to an issuer or third party
• 11.13.2025 - SC14D9C Written communication relating to third party tender offer
• 11.13.2025 - EX-99.1 EX-99.1
• 11.13.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership